Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study

Abstract Background Therapeutic drug monitoring (TDM) aims to minimize the clinical impact of posaconazole and voriconazole pharmacokinetic variability. However, its benefits on clinical outcomes are still being defined. Additionally, TDM data are limited for posaconazole IV and delayed-release tabl...

Full description

Bibliographic Details
Main Authors: Whitley M. Yi, Kelly E. Schoeppler, Jaclyn Jaeger, Scott W. Mueller, Robert MacLaren, Douglas N. Fish, Tyree H. Kiser
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Annals of Clinical Microbiology and Antimicrobials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12941-017-0235-8